by
Camgöz, Aylin.
Format:
El Yazması
Alıntı:
The mechanisms responsible for nilotinib resistance in human chronic myeloid leukemia cells/ Camgöz
by
Gencer, Emel Başak.
Format:
El Yazması
Alıntı:
Increasing chemosensitivity of chronic myeloid leukemia cells to dasatinib by targeting bioactive
by
Adan Gökbulut, Aysun, author.
Format:
El Yazması
Alıntı:
Therapeutic potentials of fisetin, hesperetin and vitexin on chronic myeloid leukemia and acute
by
Çakır, Zeynep.
Format:
El Yazması
Alıntı:
myeloid leukemia cells/ Çakır, Zeynep.
by
Kiraz, Yağmur, author.
Format:
El Yazması
Alıntı:
chronic myeloid leukemia patients/ Kiraz, Yağmur, author.
by
Kartal, Melis.
Format:
El Yazması
Alıntı:
leukemia cells and the involvement of ceramide metabolizing genes on these mechanisms/ Kartal, Melis.
by
Kartal Yandım, Melis, author.
Format:
El Yazması
Alıntı:
myeloid leukemia patients and their impact on the clinical progress / Kartal Yandım, Melis, author.
by
Demir, Ali Aslan, author.
Format:
El Yazması
Alıntı:
, human breast adenocarcinoma (MDA-MB-231) and human myeloid leukemia (U937) cells were analyzed to obtain
by
Ulu, Gizem Tuğçe, author.
Format:
El Yazması
Alıntı:
chronic myeloid leukemia (K562, HER-2-negative) cells were determined. With this approach, SKBR-3 cells